These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31907847)

  • 1. Synthesis and Application of a Long-Circulating Radiolabeled Peptide for Targeting of Osteosarcoma.
    Li Y; Li D; Wu H; Huang J; Cheng Z
    Mol Imaging Biol; 2020 Aug; 22(4):940-947. PubMed ID: 31907847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Radiolabeled TMTP1 for Long-Acting Hepatocellular Carcinoma Therapeutics.
    Yao L; Wen X; Guo W; Fang J; Zhang X; Guo Z; Huang J; Li Y
    Mol Pharm; 2022 Sep; 19(9):3178-3186. PubMed ID: 35972772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
    Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
    Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma.
    Li Y; Zhang D; Shi Y; Guo Z; Wu X; Ren JL; Zhang X; Wu H
    Contrast Media Mol Imaging; 2016 Jul; 11(4):262-71. PubMed ID: 26931574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S; Hoppmann S; Xu Y; Cheng Z
    Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
    Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
    J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice.
    Lo WL; Lo SW; Chen SJ; Chen MW; Huang YR; Chen LC; Chang CH; Li MH
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for
    Umbricht CA; Benešová M; Hasler R; Schibli R; van der Meulen NP; Müller C
    Mol Pharm; 2018 Dec; 15(12):5556-5564. PubMed ID: 30376344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.
    Nedrow JR; Latoche JD; Day KE; Modi J; Ganguly T; Zeng D; Kurland BF; Berkman CE; Anderson CJ
    Mol Imaging Biol; 2016 Jun; 18(3):402-10. PubMed ID: 26552656
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Chen X; Sun Y; Li F; Xi L; Dai J; Zhao C; Dong Q
    Am J Nucl Med Mol Imaging; 2024; 14(2):110-121. PubMed ID: 38737640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog
    Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X
    J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelator boosted tumor-retention and pharmacokinetic properties: development of
    Zhang T; Ma X; Xu M; Cai J; Cai J; Cao Y; Zhang Z; Ji X; He J; Cabrera GOF; Wu X; Zhao W; Wu Z; Xie J; Li Z
    Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3322-3333. PubMed ID: 38771516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo small-animal PET/CT of EphB4 receptors using 64Cu-labeled peptide.
    Xiong C; Huang M; Zhang R; Song S; Lu W; Flores L; Gelovani J; Li C
    J Nucl Med; 2011 Feb; 52(2):241-8. PubMed ID: 21233177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 64Cu-labeled PEGylated polyethylenimine for cell trafficking and tumor imaging.
    Li ZB; Chen K; Wu Z; Wang H; Niu G; Chen X
    Mol Imaging Biol; 2009; 11(6):415-23. PubMed ID: 19430846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.